Familial polycythemia vera with non-germ line JAK2V617F mutation sparing the abnormal and clonal granulopoiesis

被引:9
作者
Hussein, K. [1 ]
Bock, O.
Ballmaier, M.
Goehring, G.
Steinemann, D.
Lehmann, U.
Kemper, J.
Buhr, T.
Kreipe, H.
机构
[1] Showa Univ, Sch Med, Dept Hematol, Tokyo 142, Japan
[2] Showa Univ, Sch Med, Dept Pathol 2, Tokyo 142, Japan
关键词
D O I
10.1038/sj.leu.2404846
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2566 / 2568
页数:4
相关论文
共 8 条
[1]   Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders [J].
Bellanne-Chantelot, Christine ;
Chaumarel, Isabelle ;
Labopin, Myriarn ;
Bellanger, Florence ;
Barbu, Veronique ;
De Toma, Claudia ;
Delhommeau, Frangois ;
Casadevall, Nicole ;
Vainchenker, William ;
Thomas, Gilles ;
Najman, Albert .
BLOOD, 2006, 108 (01) :346-352
[2]   Detection of the single hotspot mutation in the JH2 pseuclokinase domain of janus kinase 2 in bone marrow trephine biopsies derived from chronic myeloproliferative disorders [J].
Bock, O ;
Büsche, G ;
Koop, C ;
Schröter, S ;
Buhr, T ;
Kreipe, H .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (02) :170-177
[3]   The polycythaemia rubra vera-1 gene is constitutively expressed by bone marrow cells and does not discriminate polycythaemia vera from reactive and other chronic myeloproliferative disorders [J].
Bock, O ;
Serinsöz, E ;
Neusch, M ;
Schlué, J ;
Kreipe, H .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (03) :472-474
[4]   B-CLL developing in a patient with PV is not affected by V617F mutation of the Janus kinase 2 [J].
Hussein, Kais ;
Brakensiek, Kai ;
Ballmaier, Matthias ;
Bormann, Matthias ;
Goehring, Gudrun ;
Buhr, Thomas ;
Bock, Oliver ;
Kreipe, Hans .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 77 (06) :539-541
[5]   Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders [J].
Kralovics, Robert ;
Teo, Soon-Siong ;
Li, Sai ;
Theocharides, Alexandre ;
Buser, Andreas S. ;
Tichelli, Andre ;
Skoda, Radek G. .
BLOOD, 2006, 108 (04) :1377-1380
[6]   Biomarker analysis in polycythemia vera under interferon-alpha treatment: clonality, EEC, PRV-1, and JAK2 V617F [J].
Steimle, C. ;
Lehmann, U. ;
Temerinac, S. ;
Goerttler, Ph. S. ;
Kreipe, H. ;
Meinhardt, G. ;
Heimpel, H. ;
Pahl, H. L. .
ANNALS OF HEMATOLOGY, 2007, 86 (04) :239-244
[7]   Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization [J].
Steinemann, Doris ;
Skawran, Britta ;
Becker, Thomas ;
Tauscher, Marcel ;
Weigmann, Anja ;
Wingen, Luzie ;
Tauscher, Sarah ;
Hinrichsen, Tanja ;
Hertz, Sabine ;
Flemming, Peer ;
Flik, Jacobus ;
Wiese, Birgit ;
Kreipe, Hans ;
Lichter, Peter ;
Schlegelberger, Brigitte ;
Wilkens, Ludwig .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (10) :1283-1291
[8]   JAK2V617F mutation can occur exclusively in the erythroid lineage and be absent in granulocytes and progenitor cells in classic myeloproliferative disorders [J].
Zehentner, Barbara K. ;
Loken, Michael R. ;
Wells, Denise A. .
AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (10) :806-807